During an in-clinic follow-up, an episode of ventricular tachycardia (vt) was noted on the device which was incorrectly interpreted as a supraventricular tachycardia (svt) and resulted in delayed therapy.The device was later able to correctly interpret the arrhythmia and delivered appropriate therapy.Abbott technical support was contacted and noted the device behaved appropriately according to its programmed settings.New programming parameters were provided in order to avoid any future delayed therapy.Reprogramming is anticipated, however, no intervention was performed at this time.The patient was stable and will continue to be monitored.
|